In this case, some functional inactivating TREX1 variants may have opposing effects on different disease phenotypes, promoting the autoimmune disease (if they are present in the germline), but potentially limiting cancer emergence and progression by inhibiting TREX1 suppression of antitumor immunity. This evidence concerns the gene TREX1 and autoimmune disease.